CLINICAL_TRIALS
trial_result
· 2017-02-01
Clinical Trial Update: Evaluation of the Safety and Efficacy of a Single Dose of a Dengue Vaccine (TV005) in Healthy Adults [Phase 1]
Summary
Phase 1 trial evaluating safety and efficacy of a single-dose Dengue vaccine TV005 in healthy adults; the study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Dengue | Phase 1 | Status: COMPLETED